BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 16949842)

  • 21. Induction of high-molecular-weight (HMW) tumor necrosis factor(TNF) alpha by hepatitis C virus (HCV) non-structural protein 3 (NS3) in liver cells is AP-1 and NF-kappaB-dependent activation.
    Hassan M; Selimovic D; Ghozlan H; Abdel-Kader O
    Cell Signal; 2007 Feb; 19(2):301-11. PubMed ID: 16916598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Network based analysis of hepatitis C virus core and NS4B protein interactions.
    Tripathi LP; Kataoka C; Taguwa S; Moriishi K; Mori Y; Matsuura Y; Mizuguchi K
    Mol Biosyst; 2010 Dec; 6(12):2539-53. PubMed ID: 20953506
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis C virus-core and non structural proteins lead to different effects on cellular antioxidant defenses.
    Abdalla MY; Ahmad IM; Spitz DR; Schmidt WN; Britigan BE
    J Med Virol; 2005 Aug; 76(4):489-97. PubMed ID: 15977232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subcellular localization of HCV core protein regulates its ability for p53 activation and p21 suppression.
    Yamanaka T; Kodama T; Doi T
    Biochem Biophys Res Commun; 2002 Jun; 294(3):528-34. PubMed ID: 12056798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impairment of interferon regulatory factor-3 activation by hepatitis C virus core protein basic amino acid region 1.
    Inoue K; Tsukiyama-Kohara K; Matsuda C; Yoneyama M; Fujita T; Kuge S; Yoshiba M; Kohara M
    Biochem Biophys Res Commun; 2012 Nov; 428(4):494-9. PubMed ID: 23122814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of p53 transcription regulatory activity and post-translational modification by hepatitis C virus core protein.
    Kao CF; Chen SY; Chen JY; Wu Lee YH
    Oncogene; 2004 Apr; 23(14):2472-83. PubMed ID: 14968111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of Chemokines by Hepatitis C Virus Proteins: Synergy of the Core Protein with Interleukin-1β and Interferon-γ in Liver Bystander Cells.
    Abouelasrar Salama S; Gouwy M; De Zutter A; Pörtner N; Vanbrabant L; Berghmans N; De Buck M; Struyf S; Van Damme J
    J Interferon Cytokine Res; 2020 Apr; 40(4):195-206. PubMed ID: 32031878
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complex formation of the nonstructural protein 3 of hepatitis C virus with the p53 tumor suppressor.
    Ishido S; Hotta H
    FEBS Lett; 1998 Nov; 438(3):258-62. PubMed ID: 9827557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis C virus core from two different genotypes has an oncogenic potential but is not sufficient for transforming primary rat embryo fibroblasts in cooperation with the H-ras oncogene.
    Chang J; Yang SH; Cho YG; Hwang SB; Hahn YS; Sung YC
    J Virol; 1998 Apr; 72(4):3060-5. PubMed ID: 9525629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel combined vaccine candidate containing epitopes of HCV NS3, core and E1 proteins induces multi-specific immune responses in BALB/c mice.
    Zeng R; Li G; Ling S; Zhang H; Yao Z; Xiu B; He F; Huang R; Wei L
    Antiviral Res; 2009 Oct; 84(1):23-30. PubMed ID: 19646486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human dendritic cells expressing hepatitis C virus core protein display transcriptional and functional changes consistent with maturation.
    Landi A; Yu H; Babiuk LA; van Drunen Littel-van den Hurk S
    J Viral Hepat; 2011 Oct; 18(10):700-13. PubMed ID: 20701679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunization against hepatitis C virus with a fusion protein containing the extra domain A from fibronectin and the hepatitis C virus NS3 protein.
    Mansilla C; Gorraiz M; Martinez M; Casares N; Arribillaga L; Rudilla F; Echeverria I; Riezu-Boj JI; Sarobe P; Borrás-Cuesta F; Prieto J; Lasarte JJ
    J Hepatol; 2009 Sep; 51(3):520-7. PubMed ID: 19596480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complex formation between hepatitis C virus NS2 and NS3 proteins.
    Kiiver K; Merits A; Ustav M; Zusinaite E
    Virus Res; 2006 May; 117(2):264-72. PubMed ID: 16324764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hepatocyte transformation and tumor development induced by hepatitis C virus NS3 N-terminal protein].
    He QQ; Cheng RX; Sun Y; Feng DY; Zheng H
    Zhonghua Bing Li Xue Za Zhi; 2003 Jun; 32(3):255-9. PubMed ID: 12882694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood.
    Beld M; Penning M; van Putten M; Lukashov V; van den Hoek A; McMorrow M; Goudsmit J
    Hepatology; 1999 Apr; 29(4):1288-98. PubMed ID: 10094977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of expression of hepatitis C virus 1b genotype core and NS4B genes in HepG2 cells using artificial microRNAs.
    Jiang XH; Xie YT; Jiang B; Tang MY; Ma T; Peng H
    Mol Med Rep; 2015 Aug; 12(2):1905-13. PubMed ID: 25847260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The NS3 protein of hepatitis C virus induces caspase-8-mediated apoptosis independent of its protease or helicase activities.
    Prikhod'ko EA; Prikhod'ko GG; Siegel RM; Thompson P; Major ME; Cohen JI
    Virology; 2004 Nov; 329(1):53-67. PubMed ID: 15476874
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis C virus core protein-induced loss of LZIP function correlates with cellular transformation.
    Jin DY; Wang HL; Zhou Y; Chun AC; Kibler KV; Hou YD; Kung H; Jeang KT
    EMBO J; 2000 Feb; 19(4):729-40. PubMed ID: 10675342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of hepatitis C virus nonstructural protein NS3 on telomerase activity].
    Ouyang X; Cheng R; Feng D; Zheng H
    Zhonghua Bing Li Xue Za Zhi; 2001 Dec; 30(6):443-7. PubMed ID: 11866988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The nucleotide binding motif of hepatitis C virus NS4B can mediate cellular transformation and tumor formation without Ha-ras co-transfection.
    Einav S; Sklan EH; Moon HM; Gehrig E; Liu P; Hao Y; Lowe AW; Glenn JS
    Hepatology; 2008 Mar; 47(3):827-35. PubMed ID: 18081150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.